Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ficlatuzumab is a humanized monoclonal antibody that specifically targets and neutralizes the biological activity of human hepatocyte growth factor (HGF), by inhibiting HGF, Ficlatuzumab effectively blocks c-Met receptor-mediated downstream signaling pathways responsible for cancer cell proliferation, migration, and invasion, demonstrating applicable use for the treatment of squamous cell carcinoma.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $147 | In Stock | |
5 mg | $446 | In Stock | |
10 mg | $762 | In Stock | |
25 mg | $1,130 | In Stock | |
50 mg | $1,530 | In Stock |
Description | Ficlatuzumab is a humanized monoclonal antibody that specifically targets and neutralizes the biological activity of human hepatocyte growth factor (HGF), by inhibiting HGF, Ficlatuzumab effectively blocks c-Met receptor-mediated downstream signaling pathways responsible for cancer cell proliferation, migration, and invasion, demonstrating applicable use for the treatment of squamous cell carcinoma. |
In vitro | Ficlatuzumab (20 μg/mL, 24 hours) treatment of HNSCC cells can effectively reduce the migration and invasion of HNSCC cells promoted by tumor-associated fibroblast (TAF) culture medium, and can also reduce the epithelial-mesenchymal transition (EMT) and vimentin expression of HNSCC cells promoted by TAF. [1] |
Cas No. | 1174900-84-5 |
Color | Transparent |
Appearance | Liquid |
Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.